
### [MONDO:0018282](http://purl.obolibrary.org/obo/MONDO_0018282)
**Label:** qualitative or quantitative defects of alpha-dystroglycan

**Subclasses:** [MONDO:0014101](http://purl.obolibrary.org/obo/MONDO_0014101) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 12), [MONDO:0014489](http://purl.obolibrary.org/obo/MONDO_0014489) (limb-girdle muscular dystrophy due to POMK deficiency), [MONDO:0014120](http://purl.obolibrary.org/obo/MONDO_0014120) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13), [MONDO:0014022](http://purl.obolibrary.org/obo/MONDO_0014022) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 10), [MONDO:0014683](http://purl.obolibrary.org/obo/MONDO_0014683) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9), [MONDO:0016184](http://purl.obolibrary.org/obo/MONDO_0016184) (qualitative or quantitative defects of protein O-mannosyltransferase 1), [MONDO:0016183](http://purl.obolibrary.org/obo/MONDO_0016183) (qualitative or quantitative defects of protein glycosyltransferase-like), [MONDO:0016185](http://purl.obolibrary.org/obo/MONDO_0016185) (qualitative or quantitative defects of protein O-mannosyltransferase 2), [MONDO:0018283](http://purl.obolibrary.org/obo/MONDO_0018283) (primary qualitative or quantitative defects of alpha-dystroglycan), [MONDO:0018280](http://purl.obolibrary.org/obo/MONDO_0018280) (muscle-eye-brain disease with bilateral multicystic leucodystrophy), [MONDO:0016182](http://purl.obolibrary.org/obo/MONDO_0016182) (qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase), [MONDO:0012248](http://purl.obolibrary.org/obo/MONDO_0012248) (autosomal recessive limb-girdle muscular dystrophy type 2K), [MONDO:0013835](http://purl.obolibrary.org/obo/MONDO_0013835) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 7), [MONDO:0013162](http://purl.obolibrary.org/obo/MONDO_0013162) (autosomal recessive limb-girdle muscular dystrophy type 2N), [MONDO:0016155](http://purl.obolibrary.org/obo/MONDO_0016155) (qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan), [MONDO:0012652](http://purl.obolibrary.org/obo/MONDO_0012652) (autosomal recessive limb-girdle muscular dystrophy type 2L), [MONDO:0019523](http://purl.obolibrary.org/obo/MONDO_0019523) (Walker-Warburg syndrome), [MONDO:0016157](http://purl.obolibrary.org/obo/MONDO_0016157) (qualitative or quantitative defects of fukutin), [MONDO:0014474](http://purl.obolibrary.org/obo/MONDO_0014474) (autosomal recessive limb-girdle muscular dystrophy type 2U), [MONDO:0013440](http://purl.obolibrary.org/obo/MONDO_0013440) (autosomal recessive limb-girdle muscular dystrophy type 2P), [MONDO:0016156](http://purl.obolibrary.org/obo/MONDO_0016156) (qualitative or quantitative defects of FKRP), [MONDO:0013161](http://purl.obolibrary.org/obo/MONDO_0013161) (autosomal recessive limb-girdle muscular dystrophy type 2O), [MONDO:0013904](http://purl.obolibrary.org/obo/MONDO_0013904) (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8), [MONDO:0011787](http://purl.obolibrary.org/obo/MONDO_0011787) (autosomal recessive limb-girdle muscular dystrophy type 2I), [MONDO:0012699](http://purl.obolibrary.org/obo/MONDO_0012699) (autosomal recessive limb-girdle muscular dystrophy type 2M), 

**Corr. equiv. classes:** [Orphanet:34515](http://www.orpha.net/ORDO/Orphanet_34515), [Orphanet:207113](http://www.orpha.net/ORDO/Orphanet_207113), [Orphanet:280333](http://www.orpha.net/ORDO/Orphanet_280333), [Orphanet:206564](http://www.orpha.net/ORDO/Orphanet_206564), [Orphanet:209033](http://www.orpha.net/ORDO/Orphanet_209033), [OMIM:616052](http://purl.obolibrary.org/obo/OMIM_616052), [OMIM:615041](http://purl.obolibrary.org/obo/OMIM_615041), [Orphanet:86812](http://www.orpha.net/ORDO/Orphanet_86812), [OMIM:616094](http://purl.obolibrary.org/obo/OMIM_616094), [Orphanet:209030](http://www.orpha.net/ORDO/Orphanet_209030), [OMIM:615287](http://purl.obolibrary.org/obo/OMIM_615287), [OMIM:616538](http://purl.obolibrary.org/obo/OMIM_616538), [OMIM:614830](http://purl.obolibrary.org/obo/OMIM_614830), [OMIM:611588](http://purl.obolibrary.org/obo/OMIM_611588), [OMIM:615249](http://purl.obolibrary.org/obo/OMIM_615249), [Orphanet:207119](http://www.orpha.net/ORDO/Orphanet_207119), [OMIM:607155](http://purl.obolibrary.org/obo/OMIM_607155), [Orphanet:899](http://www.orpha.net/ORDO/Orphanet_899), [OMIM:611307](http://purl.obolibrary.org/obo/OMIM_611307), [Orphanet:206549](http://www.orpha.net/ORDO/Orphanet_206549), [Orphanet:352479](http://www.orpha.net/ORDO/Orphanet_352479), [Orphanet:207122](http://www.orpha.net/ORDO/Orphanet_207122), [Orphanet:445110](http://www.orpha.net/ORDO/Orphanet_445110), [OMIM:609308](http://purl.obolibrary.org/obo/OMIM_609308), [Orphanet:209027](http://www.orpha.net/ORDO/Orphanet_209027), [Orphanet:209024](http://www.orpha.net/ORDO/Orphanet_209024), [OMIM:613157](http://purl.obolibrary.org/obo/OMIM_613157), [Orphanet:371040](http://www.orpha.net/ORDO/Orphanet_371040), [OMIM:613158](http://purl.obolibrary.org/obo/OMIM_613158), [OMIM:614643](http://purl.obolibrary.org/obo/OMIM_614643), [Orphanet:206554](http://www.orpha.net/ORDO/Orphanet_206554), [Orphanet:206559](http://www.orpha.net/ORDO/Orphanet_206559), [OMIM:613818](http://purl.obolibrary.org/obo/OMIM_613818), [Orphanet:370997](http://www.orpha.net/ORDO/Orphanet_370997), 

**Class expressions from DL-Learner:**

- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) 43.19%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 41.90%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 41.47%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 41.06%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 41.06%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 41.06%
- [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 40.90%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 40.02%
- [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 39.75%
- [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) and [HP:0003560](http://purl.obolibrary.org/obo/HP_0003560) (Muscular dystrophy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 38.96%
- [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 32.40%
- [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) 32.35%
- [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) 30.69%
- [HP:0003236](http://purl.obolibrary.org/obo/HP_0003236) (Elevated serum creatine phosphokinase) 30.59%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 27.10%


